{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:41:00Z","timestamp":1790685660508,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejca.2021.04.026","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T06:52:24Z","timestamp":1622271144000},"page":"4-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["European trends in breast cancer mortality, 1980\u20132017 and predictions to 2025"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-1893","authenticated-orcid":false,"given":"Cezary","family":"Wojtyla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bertuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wojtyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.04.026_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2017.06.003","article-title":"Trends and predictions to 2020 in breast cancer mortality in Europe","volume":"36","author":"Carioli","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2021.04.026_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GCO.0000000000000153","article-title":"Update on breast cancer risk prediction and prevention","volume":"27","author":"Sestak","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejca.2021.04.026_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdw544","article-title":"ESOESMO international consensus guidelines for advanced breast cancer (ABC 3)","volume":"28","author":"Cardoso","year":"2017","journal-title":"Ann Oncol"},{"issue":"9935","key":"10.1016\/j.ejca.2021.04.026_bib4","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.04.026_bib5","doi-asserted-by":"crossref","first-page":"1203e10","DOI":"10.1056\/NEJMoa1000727","article-title":"Effect of screening mammography on breast-cancer mortality in Norway","volume":"363","author":"Kalager","year":"2010","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ejca.2021.04.026_bib6","first-page":"30088","article-title":"Landmark trials in the medical oncology management of early stage breast cancer","volume":"30","author":"Hensing","year":"2020","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2021.04.026_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2019.11.018","article-title":"Cervical cancer mortality in young adult European women","volume":"126","author":"Wojtyla","year":"2020","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.04.026_bib8","series-title":"Premature death in the new independent states","author":"Bobadilla","year":"1997"},{"issue":"1","key":"10.1016\/j.ejca.2021.04.026_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11205-017-1764-4","article-title":"Convergence or divergence? Life expectancy patterns in post-communist countries, 1959-2010","volume":"140","author":"Gerry","year":"2018","journal-title":"Soc Indicat Res"},{"key":"10.1016\/j.ejca.2021.04.026_bib10","series-title":"The mortality crisis in transitional economies","author":"Cornia","year":"2000"},{"key":"10.1016\/j.ejca.2021.04.026_bib11","unstructured":"World Health Organization Statistical Information System. WHO mortality database; http:\/\/www.who.int\/healthinfo\/statistics\/mortality_rawdata\/en\/index.html [Accessed on 20th July 2020]."},{"key":"10.1016\/j.ejca.2021.04.026_bib12","series-title":"International classification of disease: 8th revision","year":"1967"},{"key":"10.1016\/j.ejca.2021.04.026_bib13","series-title":"International classification of disease: 9th revision","year":"1977"},{"key":"10.1016\/j.ejca.2021.04.026_bib14","series-title":"International classification of disease and related health problems: 10th revision","year":"1992"},{"key":"10.1016\/j.ejca.2021.04.026_bib15","unstructured":"European Commission. Eurostat population database; http:\/\/epp.eurostat.ec.europa.eu\/portal\/page\/portal\/population\/data\/database [Accessed on 20th July 2020]. ."},{"key":"10.1016\/j.ejca.2021.04.026_bib16","first-page":"671","article-title":"Comparison between registries: age-standardized rates","volume":"vol. IV","author":"Doll","year":"1982","journal-title":"IARC Sci"},{"key":"10.1016\/j.ejca.2021.04.026_bib17","unstructured":"National Cancer Institute. Joinpoint regression program, version 4.6.0.0."},{"key":"10.1016\/j.ejca.2021.04.026_bib18","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2021.04.026_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates. (Erratum in: stat Med 2001;20: 655)","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.ejca.2021.04.026_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/annonc\/mdz051","article-title":"European cancer mortality predictions for the year 2019 with focus on breast cancer","volume":"30","author":"Malvezzi","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2021.04.026_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/aoms.2019.85198","article-title":"Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+)","volume":"16","author":"Koczkodaj","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ejca.2021.04.026_bib22","series-title":"Cancer screening in the European union. Report on the implementation of the council recommendation on cancer screening","author":"Ponti","year":"2017"},{"key":"10.1016\/j.ejca.2021.04.026_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/eurpub\/ckt131","article-title":"Delays in diagnosis and treatment of breast cancer: a multinational analysis","volume":"24","author":"Jassem","year":"2014","journal-title":"Eur J Publ Health"},{"key":"10.1016\/j.ejca.2021.04.026_bib24","unstructured":"Cancer Research UK. Breast cancer treatment statistics, https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/diagnosis-and-treatment#ref-2 [accessed 24 March 2021]."},{"key":"10.1016\/j.ejca.2021.04.026_bib25","series-title":"Female oncologic Diseases in Romania","year":"2016"},{"issue":"3","key":"10.1016\/j.ejca.2021.04.026_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172351","article-title":"Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA","volume":"12","author":"Ades","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2021.04.026_bib27","article-title":"Breast cancer","volume":"14","author":"Jassem","year":"2018","journal-title":"Oncol Clin Pract"},{"key":"10.1016\/j.ejca.2021.04.026_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajog.2014.06.048","article-title":"Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts","volume":"212","author":"Scheel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2021.04.026_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/M14-0692","article-title":"Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts","volume":"162","author":"Sprague","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2021.04.026_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.2251011667","article-title":"Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27 825 patient evaluations","volume":"225","author":"Kolb","year":"2002","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejca.2021.04.026_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00394-014-0746-4","article-title":"Overweight and obesity in 16 European countries","volume":"54","author":"Gallus","year":"2015","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.ejca.2021.04.026_bib32","unstructured":"Eurostat. Women are having their first child at an older age. https:\/\/ec.europa.eu\/eurostat\/web\/products-eurostat-news\/-\/DDN-20190318-1 [Acessed 25th October 2020]."},{"key":"10.1016\/j.ejca.2021.04.026_bib33","unstructured":"Eurostat. Women in EU have first child on average at 29. https:\/\/ec.europa.eu\/eurostat\/documents\/2995521\/8774296\/3-28032018-AP-EN.pdf\/fdf8ebdf-a6a4-4153-9ee9-2f05652d8ee0 [Acessed 25th October 2020]."},{"key":"10.1016\/j.ejca.2021.04.026_bib34","unstructured":"European Comission. European core health indicators. https:\/\/ec.europa.eu\/health\/indicators_data\/indicators_en [Acessed 25th October 2020]."},{"issue":"3","key":"10.1016\/j.ejca.2021.04.026_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0000000000002234","article-title":"Breastfeeding rates and programs in Europe: a survey of 11 national breastfeeding committees and representatives","volume":"68","author":"Theurich","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.ejca.2021.04.026_bib36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/nu12030607","article-title":"Adherence to the world cancer research fund\/American institute for cancer research recommendations and the risk of breast cancer","volume":"12","author":"Turati","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.ejca.2021.04.026_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnci\/90.5.389","article-title":"Population attributable risk for breast cancer: diet, nutrition, and physical exercise","volume":"90","author":"Mezzetti","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ejca.2021.04.026_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000503219","article-title":"Breast cancer statistics in the European union: incidence and survival across European countries","volume":"14","author":"Dafni","year":"2019","journal-title":"Breast Care"},{"issue":"6","key":"10.1016\/j.ejca.2021.04.026_bib39","first-page":"438","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejca.2021.04.026_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.breast.2017.12.004","article-title":"Trends and predictions to 2020 in breast cancer mortality: Americas and Australasia","volume":"37","author":"Carioli","year":"2018","journal-title":"Breast"},{"issue":"9814","key":"10.1016\/j.ejca.2021.04.026_bib41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Peto","year":"2012","journal-title":"Lancet"},{"issue":"9472","key":"10.1016\/j.ejca.2021.04.026_bib42","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"9793","key":"10.1016\/j.ejca.2021.04.026_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"issue":"9897","key":"10.1016\/j.ejca.2021.04.026_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)61094-6","article-title":"Herceptin Adjuvant (HERA) Trial Study Team. 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial","volume":"382","author":"Goldhirsch","year":"2013","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ejca.2021.04.026_bib45","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ejca.2021.04.026_bib46","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1200\/JCO.2011.35.0868","article-title":"Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31","volume":"29","author":"Perez","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9804","key":"10.1016\/j.ejca.2021.04.026_bib47","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.04.026_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.33460","article-title":"Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures","author":"Nyante","year":"2021","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:31:05Z","timestamp":1760733065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":48,"alternative-id":["S0959804921002720"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.04.026","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European trends in breast cancer mortality, 1980\u20132017 and predictions to 2025","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}